Use of Novel Mobile Technology to Screen Sexual Partners for HIV and STIs

使用新型移动技术筛查性伴侣的艾滋病毒和性传播感染

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Increasing incidence of HIV and STIs among men who have sex with men (MSM) and transgender women (TGW) highlight the need for novel approaches to reducing infections-especially among individuals who do not use condoms consistently. Our prior studies on the use of rapid HIV self-testing (ST) by MSM who regularly engage in high-risk sexual behavior, show that these men are willing to use ST with partners, avoid intercourse in situations where partners test HIV-positive, and, over time tend to reduce their high-risk sexual behavior. This proposed study expands this line of research by exploring the use of a new device, the mChip dongle. Developed at the Columbia University School of Engineering, this device uses smartphone technology to analyze a drop of blood and test it for HIV and syphilis antibodies. The mChip dongle brings more precision to ST, tests for HIV and syphilis and potentially other STIs, and can capitalize on smartphone technology to provide clearer user instructions, on-hand information about HIV/STI, remote monitoring of the its use, and linkage of newly diagnosed individuals to care. For this proposed quantitative and qualitative study, we will again focus on HIV-uninfected MSM and TGW with multiple sexual partners who know how to prevent HIV infection, yet engage in high-risk sexual behavior. The Specific Aims are to: 1) Assess acceptability among MSM and TGW of using the mChip dongle to test sexual partners; 2) Optimize the smartphone app and mChip dongle for home use; and 3) Assess the feasibility of using the mChip dongle to test sexual partners, including: a) frequency of use of the mChip dongle with sexual partners over 3 months; b) factors associated with mChip dongle use or non-use; c) condom use with partners who were not screened vs. partners screened HIV or STI- negative with the mChip dongle; and d) factors associated with changes in sexual risk behavior over 3 months. The study consists of two phases. In Phase 1A, 60 participants will undergo a quantitative, qualitative, and skill-demonstration assessment (using the mChip dongle in front of the interviewer) in a single study visit. Phase 1A findings wil inform Phase 1B, which focuses on revising the smartphone app and mChip dongle for home users, as well as revisions to the Phase 2 assessment. In Phase 2A, 80 new participants will undergo a baseline quantitative and skill-demonstration assessment in order to screen for 50 participants who will be invited into the Phase 2B 3-month study. These 50 participants will be provided with an mChip dongle and given the choice to use it to screen sexual partners. After 3 months participants will undergo a quantitative and qualitative interview about experiences using (or not using) the mChip dongle with partners. This study will capitalize on a critical juncture in the development of the mChip dongle by systematically engaging its intended users in offering feedback to the engineering team on how to optimize its usability and acceptability among high-risk populations. This study will also allow us to assess the feasibility of conducting a larger and longer trial to develop and test an mChip-based harm-reduction intervention.
 描述(通过应用程序证明):艾滋病毒敏人的发病率与男性(MSM)和变性妇女(TGW)发生性关系,以减少我们先前使用避孕套的人的感染。艾滋病毒的自我测试(ST)是MSM的,他们经常在伴侣测试HIV阳性的地方进行性交,并且随着时间的流逝,倾向于减少其高风险的性行为。该设备的工程学院使用智能手机技术来分析血液的滴滴,并为梅毒带来的艾滋病毒和梅毒所带来的IS。新诊断的人的联系再次关注HIV-Uninf与知道可以预防艾滋病毒感染的多次性伴侣,但特定的目标是对艺术的智能手机应用程序和MCHIP加密狗用于家庭使用; 3)使用MCHIP加密狗评估盛宴,以测试性伴侣:a)与MCHIP加密狗使用的性伴侣因素的频率伴侣没有被筛选的伴侣筛选艾滋病毒或与MCHIP加密狗的几个月。在家庭用户的智能手机应用程序和MCHIP加密狗上,以及第2阶段评估的修订。三个月的研究。系统地吸引其预期的用户向工程团队提供有关如何优化高风险普及的TY和可接受性的反馈。损害回合的间隔。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ivan C Balan其他文献

Ivan C Balan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ivan C Balan', 18)}}的其他基金

Integration of Electronic SBI(RT) into an HIV Testing Program to Reduce Substance Use and HIV risk Behavior among MSM in Argentina
将电子 SBI(RT) 纳入 HIV 检测计划,以减少阿根廷 MSM 的药物使用和 HIV 风险行为
  • 批准号:
    10402058
  • 财政年份:
    2022
  • 资助金额:
    $ 57.69万
  • 项目类别:
Integration of Electronic SBI(RT) into an HIV Testing Program to Reduce Substance Use and HIV risk Behavior among MSM in Argentina
将电子 SBI(RT) 纳入 HIV 检测计划,以减少阿根廷 MSM 的药物使用和 HIV 风险行为
  • 批准号:
    10669561
  • 财政年份:
    2022
  • 资助金额:
    $ 57.69万
  • 项目类别:
Use of Novel Mobile Technology to Screen Sexual Partners for HIV and STIs
使用新型移动技术筛查性伴侣的艾滋病毒和性传播感染
  • 批准号:
    9270044
  • 财政年份:
    2016
  • 资助金额:
    $ 57.69万
  • 项目类别:
Use of Novel Mobile Technology to Screen Sexual Partners for HIV and STIs
使用新型移动技术筛查性伴侣的艾滋病毒和性传播感染
  • 批准号:
    9133042
  • 财政年份:
    2016
  • 资助金额:
    $ 57.69万
  • 项目类别:
HIV-Prevention Intervention Targets in High-risk Alcohol Venues in Argentina
阿根廷高风险酒精场所的艾滋病毒预防干预目标
  • 批准号:
    7620532
  • 财政年份:
    2008
  • 资助金额:
    $ 57.69万
  • 项目类别:
HIV-Prevention Intervention Targets in High-risk Alcohol Venues in Argentina
阿根廷高风险酒精场所的艾滋病毒预防干预目标
  • 批准号:
    7694321
  • 财政年份:
    2008
  • 资助金额:
    $ 57.69万
  • 项目类别:

相似国自然基金

新细胞因子FAM19A4联合CTLA-4抗体在肿瘤治疗的功能和机制研究
  • 批准号:
    32370967
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于吡啶盐的可裂解抗体-药物偶联方法研究
  • 批准号:
    22307081
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
  • 批准号:
    32371262
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于淬灭抗体的重金属镉快速定量免疫分析
  • 批准号:
    22306074
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
TFAM条件性敲除重塑树突状细胞免疫代谢增强PD-1抗体抗肿瘤作用的机制研究
  • 批准号:
    82303723
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Evaluating immunity to oral human papillomavirus to understand the lower oropharyngeal cancer risk among MSM
评估对口腔人乳头瘤病毒的免疫力,以了解 MSM 中口咽癌的风险较低
  • 批准号:
    10401518
  • 财政年份:
    2021
  • 资助金额:
    $ 57.69万
  • 项目类别:
Evaluating immunity to oral human papillomavirus to understand the lower oropharyngeal cancer risk among MSM
评估对口腔人乳头瘤病毒的免疫力,以了解 MSM 中口咽癌的风险较低
  • 批准号:
    10491845
  • 财政年份:
    2021
  • 资助金额:
    $ 57.69万
  • 项目类别:
Research Project 3 Galectin-1-glycan interactions: Novel regulatory checkpoints linking immunosuppression and angiogenesis in virally induced cancers
研究项目 3 Galectin-1-聚糖相互作用:在病毒诱导的癌症中将免疫抑制和血管生成联系起来的新型调节检查点
  • 批准号:
    10488072
  • 财政年份:
    2017
  • 资助金额:
    $ 57.69万
  • 项目类别:
Research Project 3 Galectin-1-glycan interactions: Novel regulatory checkpoints linking immunosuppression and angiogenesis in virally induced cancers
研究项目 3 Galectin-1-聚糖相互作用:在病毒诱导的癌症中将免疫抑制和血管生成联系起来的新型调节检查点
  • 批准号:
    10246320
  • 财政年份:
    2017
  • 资助金额:
    $ 57.69万
  • 项目类别:
Use of Novel Mobile Technology to Screen Sexual Partners for HIV and STIs
使用新型移动技术筛查性伴侣的艾滋病毒和性传播感染
  • 批准号:
    9270044
  • 财政年份:
    2016
  • 资助金额:
    $ 57.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了